Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Biotechnology has always been a sector driven by inflection points, and few milestones matter more than Phase 2 clinical data. $NTHI, $ORKA, $ABVX, $SYRE
-
LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) investors that a lawsuit filed on behalf of investors that...
-
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
-
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Barclays PLC (“Barclays” or the...
-
Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn
-
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
-
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Barclays PLC (BCS)
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
-
LOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Barclays PLC ("Barclays" or the "Company") (NYSE:BCS) investors that a class action has been filed on behalf of investors....
-
LOS ANGELES, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Barclays PLC ("Barclays" or the "Company") (NYSE:BCS)investors that a class action has been filed on behalf of investors....